Chemomab director reports stock option holdings
Chemomab Therapeutics Ltd. director Jill M. Quigley filed an initial statement of beneficial ownership that lists her stock option holdings over the company’s American Depositary Shares.
Rhea-AI Filing Summary
Chemomab Therapeutics Ltd. director Jill M. Quigley filed an initial statement of beneficial ownership that lists her stock option holdings over the company’s American Depositary Shares. The filing shows four option grants with different exercise prices and long-dated expirations.
Quigley holds options over 3,410 ADS at an exercise price of $13.00 per share expiring on June 16, 2032; 1,714 ADS at $6.80 expiring on June 14, 2033; 2,533 ADS at $4.00 expiring on June 16, 2034; and 3,959 ADS at $5.24 expiring on June 16, 2035. Footnotes state that options granted on June 16, 2022, June 14, 2023, and June 16, 2024 are fully vested and exercisable as of the report date.
Positive
- None.
Negative
- None.
Insider Trade Summary
4 transactions reported
Mixed
4 txns
Insider
Quigley Jill M.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock option (right to buy American Depositary Shares) | -- | -- | -- |
| holding | Stock option (right to buy American Depositary Shares) | -- | -- | -- |
| holding | Stock option (right to buy American Depositary Shares) | -- | -- | -- |
| holding | Stock option (right to buy American Depositary Shares) | -- | -- | -- |
Holdings After Transaction:
Stock option (right to buy American Depositary Shares) — 11,616 contracts (Direct)
Footnotes (3)
- F1. The options reported in this row were granted to the Reporting Person by the Issuer on June 16, 2022 and are fully vested and exercisable as of the date of this report.
- F2. The options reported in this row were granted to the Reporting Person by the Issuer on June 14, 2023 and are fully vested and exercisable as of the date of this report.
- F3. The options reported in this row were granted to the Reporting Person by the Issuer on June 16, 2024 and are fully vested and exercisable as of the date of this report.
Key Figures
Option underlying shares: 3,410 ADS
Exercise price: $13.00 per ADS
Option underlying shares: 1,714 ADS
+5 more
8 metrics
Option underlying shares
3,410 ADS
Underlying shares for option at $13.00, expiring June 16, 2032
Exercise price
$13.00 per ADS
Stock option expiring June 16, 2032
Option underlying shares
1,714 ADS
Underlying shares for option at $6.80, expiring June 14, 2033
Exercise price
$6.80 per ADS
Stock option expiring June 14, 2033
Option underlying shares
2,533 ADS
Underlying shares for option at $4.00, expiring June 16, 2034
Exercise price
$4.00 per ADS
Stock option expiring June 16, 2034
Option underlying shares
3,959 ADS
Underlying shares for option at $5.24, expiring June 16, 2035
Exercise price
$5.24 per ADS
Stock option expiring June 16, 2035
Key Terms
American Depositary Shares, Stock option, fully vested and exercisable, Form 3
4 terms
Stock option financial
"Stock option (right to buy American Depositary Shares)"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
fully vested and exercisable financial
"are fully vested and exercisable as of the date of this report"
Form 3 regulatory
"initial statement of beneficial ownership typically filed on Form 3"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Chemomab Therapeutics (CMMB) disclose about Jill Quigley’s holdings on this Form 3?
The Form 3 shows director Jill M. Quigley owning several stock options over Chemomab American Depositary Shares. These options have different exercise prices and expiration dates, outlining her potential future equity exposure rather than any recent buying or selling activity.
What are the exercise prices of Jill Quigley’s Chemomab (CMMB) stock options?
The listed stock options have exercise prices of $13.00, $6.80, $4.00, and $5.24 per American Depositary Share. These prices determine how much she must pay per share if she chooses to exercise the options in the future.
When do Jill Quigley’s Chemomab (CMMB) stock options expire?
The options expire on June 16, 2032, June 14, 2033, June 16, 2034, and June 16, 2035. These long-dated expirations give Quigley many years to decide whether to exercise and convert the options into American Depositary Shares.
Are Jill Quigley’s Chemomab (CMMB) stock options already vested and exercisable?
Footnotes state options granted on June 16, 2022, June 14, 2023, and June 16, 2024 are fully vested and exercisable. This means Quigley can choose to exercise these particular grants now, subject to their exercise prices and expiration dates.
AI-generated analysis. How Rhea-AI works. Not financial advice.
